A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
Conditions:   Recurrent Acute Leukemia of Ambiguous Lineage;   Recurrent Acute Lymphoblastic Leukemia;   Recurrent Mixed Phenotype Acute Leukemia;   Refractory Acute Leukemia of Ambiguous Lineage;   Refractory Acute Lymphoblastic Leukemia;   Refractory Mixed Phenotype Acute Leukem ia Interventions:   Procedure: Biospecimen Collection;   Drug: Calaspargase Pegol-mknl;   Drug: Cytarabine;   Procedure: Echocardiography;   Drug: Fludarabine Phosphate;   Drug: Hydrocortisone Sodium Succinate;   Drug: Methotrexate;   Procedure: Multigated Acquisition Scan;   Drug: Pegasparg ...
Source: ClinicalTrials.gov - March 9, 2023 Category: Research Source Type: clinical trials